Electromed 11/7/2023 Earnings Report

Electromed EPS Results

• Actual EPS: $0.02
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Electromed Revenue Results

• Actual Revenue: $12.32 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Electromed Announcement Details

• Date: 11/7/2023
• Time: N/A
• Conference Call Date: N/A
• Conference Call Time: N/A

Electromed (NYSE:ELMD) Inc. (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components. Electromed produces private-label and branded items that meet or exceed industry quality standards, supplying home healthcare providers, sleep clinics and respiratory therapists. Its integrated manufacturing processes—from material sourcing to final assembly—aim to ensure product consistency, quick turnaround times and cost efficiencies for its customers.

Founded in 2003 and headquartered in Jacksonville, Florida, Electromed operates manufacturing and distribution facilities within the United States and maintains a growing international customer base. The company’s vertically integrated operations and emphasis on research and development support ongoing product innovation and regulatory compliance. Electromed’s management team draws on decades of experience in the medical device sector to guide strategic growth and expand market reach.